Opioid-Induced Preconditioning Is Dependent on Caveolin-3 Expression

Caveolae are flask‐like invaginations of the sarcolemmal membrane. Recently, we have shown that caveolar structural proteins, caveolins, are essential in cardiac protection and that cardiac specific overexpression of caveolin‐3 (Cav‐3 OE) results in innate cardiac protection. Additionally, we identified that opioid‐induced preconditioning (OPC) is absent when caveolae are disrupted in vitro. However, the impact of caveolin‐3 and caveolae on OPC in vivo has not been investigated. 8‐12 week old Cav‐3 OE, caveolin‐3 knockout mice (Cav‐3 KO), and control mice were exposed to 30 min ischemia/2 hr reperfusion (I/R). Cav‐3 OE and control mice were treated with naloxone, a non‐selective opioid antagonist, 10 min prior to I/R to determine whether basal protection was abolished. Cav‐3 KO and control mice were treated with SNC, a delta‐selective opioid agonist 15 min prior to I/R to induce OPC. Cav‐3 OE mice displayed endogenous cardiac protection from I/R when compared to control mice (20±2% vs. 41±2%, n=8, respectively). This endogenous protection in Cav‐3 OE mice was abolished with naloxone pretreatment (41±2%). Conversely, control mice were protected in the presence of SNC (28±1%), although no protection was observed in Cav‐3 KO mice (38±5%). These results suggest that OPC is dependent on caveolin‐3 expression and endogenous protection induced in Cav‐3 OE mice may be opioid dependent.

[1]  I. Niesman,et al.  Role of Caveolin-3 and Glucose Transporter-4 in Isoflurane-induced Delayed Cardiac Protection , 2010, Anesthesiology.

[2]  W. Schlack,et al.  Anaesthesia and myocardial ischaemia/reperfusion injury. , 2009, British journal of anaesthesia.

[3]  J. Peart,et al.  Clinical cardioprotection and the value of conditioning responses. , 2009, American journal of physiology. Heart and circulatory physiology.

[4]  P. Insel,et al.  Cardiac-Specific Overexpression of Caveolin-3 Induces Endogenous Cardiac Protection by Mimicking Ischemic Preconditioning , 2008, Circulation.

[5]  P. Insel,et al.  Caveolae as organizers of pharmacologically relevant signal transduction molecules. , 2008, Annual review of pharmacology and toxicology.

[6]  P. Insel,et al.  Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. , 2008, Journal of molecular and cellular cardiology.

[7]  H. Patel,et al.  Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. , 2007, Life sciences.

[8]  P. Insel,et al.  Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin‐1 , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  P. Insel,et al.  Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors. , 2006, American journal of physiology. Heart and circulatory physiology.

[10]  D. Lamontagne,et al.  The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia. , 2006, Archives des maladies du coeur et des vaisseaux.

[11]  P. Insel,et al.  G-protein-coupled Receptor Signaling Components Localize in Both Sarcolemmal and Intracellular Caveolin-3-associated Microdomains in Adult Cardiac Myocytes* , 2005, Journal of Biological Chemistry.

[12]  K. Jacobson,et al.  Cardioprotective effects of adenosine A1 and A 3 receptor activation during hypoxia in isolated rat cardiac myocytes , 2004, Molecular and Cellular Biochemistry.

[13]  A. Adam,et al.  A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart. , 2003, International immunopharmacology.

[14]  R. de Jonge,et al.  Preconditioning of rat hearts by adenosine A1 or A3 receptor activation. , 2002, European journal of pharmacology.

[15]  Y. Li,et al.  Dual signaling via protein kinase C and phosphatidylinositol 3'-kinase/Akt contributes to bradykinin B2 receptor-induced cardioprotection in guinea pig hearts. , 2001, Journal of molecular and cellular cardiology.

[16]  T. Yue,et al.  Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model. , 2000, European journal of pharmacology.

[17]  B. Akabayov,et al.  The role of A1/A3 adenosine receptor activation in reduction of cardiomyocyte injury caused by hypoxic stress and in induction of apoptosis in rat cardiomyocyte cultures. , 2000, Advances in experimental medicine and biology.

[18]  F. Crea,et al.  Effects of naloxone on myocardial ischemic preconditioning in humans. , 1999, Journal of the American College of Cardiology.

[19]  J. Weil,et al.  Localization of preproenkephalin mRNA in rat heart: selective gene expression in left ventricular myocardium. , 1998, American journal of physiology. Heart and circulatory physiology.

[20]  A. Hsu,et al.  Ischemic Preconditioning in the Intact Rat Heart Is Mediated by δ1- But Not μ- or κ-Opioid Receptors , 1998 .

[21]  A. Hsu,et al.  Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. , 1998, Circulation.

[22]  A. Hsu,et al.  Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. , 1996, Circulation research.

[23]  G. Gross,et al.  Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. , 1995, The American journal of physiology.

[24]  G. Gross,et al.  Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+ channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. , 1993, Circulation research.

[25]  G. Gross,et al.  Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. , 1993, The American journal of physiology.